Dr. Donna C. Graves, MD

Dr. Graves practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Graves' NPI, 1578766192, was assigned on June 10, 2007. Dr. Graves graduated from Mercer University School of Medicine in 2005. Dr. Graves holds North Carolina license 2014-00575.

Dr. Graves' primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Graves' primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Graves is also affiliated with Atrium Health Union. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Graves to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graves practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Graves' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Graves is licensed in North Carolina.

CMS data shows 87 Medicare services from Dr. Graves across 2 procedure codes in 2024, all of them office visits, for 64 Medicare patients. Medicare paid $6,528 for them. Every service was in an office.

CMS counts 64 Medicare patients who saw Dr. Graves in 2024. The largest group is under 65, with 29 patients. 63% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Graves' median patient age at 59, with 76% women.

In 2024, Dr. Graves wrote 1,149 Medicare Part D claims for 151 patients. 88% of them were for generic drugs. CMS names the drug for 912 of them, across 32 drugs with 11 or more claims each, at $814,483 in total drug cost. In 2023, CMS named 1,083 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Graves for performance year 2024, reported through an alternative payment model (APM). Dr. Graves accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Graves as offering telehealth.

Dmand AI links 14 papers to Dr. Graves, published from 2012 to 2016. 2012 was the busiest year, with 4. The most frequent topics are Adrenal Cortex Hormones, Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Immunotherapy. Dr. Graves has published most often in Pediatr Neurol. Dr. Graves' most frequent co-authors are Allen Douglas Desena, MD, Benjamin M. Greenberg, MD and Elliot Mark Frohman, MD, PhD.

Dmand AI links Dr. Graves to 2 clinical trials. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Genzyme, a Sanofi Company sponsors the most, 2. Open Payments lists research payments to Dr. Graves that name 2 trials.

CMS Open Payments shows 267 general payments to Dr. Graves from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Sanofi and Genzyme US Companies paid the most, $69,318. It also lists 16 research payments totaling $5,319 from 2018 to 2019, naming 2 clinical trials.

Dr. Graves graduated from Mercer University School of Medicine in 2005.